Viatris Inc., based in Canonsburg, US, produces and distributes branded and generic medicines for a range of therapeutic needs.
Founded in 1993 in Canonsburg, US, Viatris Inc. produces and distributes branded and generic medicines for noncommunicable and infectious diseases. Its customers include healthcare providers, pharmacies, hospitals, and patients in markets such as the United States, Europe, Asia, and Latin America. Scott Smith is CEO. In December 2025, Biocon Limited, a portfolio company of Kotak Alternate Asset Managers, agreed to acquire Viatris Inc. for USD 815 million in cash.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in